Outcomes of Temporary Vascular Access and Factors Influencing Delayed Arteriovenous Fistula Creation
Abstract
Introduction: Haemodialysis is Malaysia's main modality of kidney replacement therapy (KRT) for end-stage kidney disease patients. However, most of the patients needed for long-term KRT are initiated with intermittent haemodialysis via a central venous catheter before placement of an arteriovenous fistula (AVF) or arteriovenous graft (AVG). Objectives: This study aimed to identify types of vascular access among incident end-stage kidney disease patients on intermittent haemodialysis and to determine the proportion of vascular access-related complications. We also aimed to study the factors that contributed to the delay in AVF creation at our institution. Methods: This is a single-centre, retrospective study of CKD stage 5 patients who were initiated on intermittent haemodialysis between 1st January 2021 and 31st December 2021. Data were collected from the medical record unit of Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan. Demographic data, comorbidities, catheter-related complications, factors associated with mortality, and delayed AVF creation were analyzed using SPSS version 27. The association between types of a catheter with complication were analyzed by chi-square test. A P-value of less than 0.05 was considered statistically significant.Results: A total of 74 patients started on intermittent haemodialysis were identified. Of these, males were 52.7 %, and females were 47.3 %. Most patients were of Malay ethnicity, with a mean age of 55 years old. Most of them have comorbidities of hypertension 95.9%, diabetes 79.7% and ischemic heart diseases 23%. Majority of them were initiated on haemodialysis with an uncuffed femoral catheter, 93.2% and later, changed to the uncuffed internal jugular catheter, 71.6%. The highest complication seen was central line-associated bloodstream infections (CLABSI) (17.6%), followed by hematoma (8.5%). There was no significant association between the types of haemodialysis catheters used with their complications. The delay in AVF creation was due to patient’s fear (36.2%) and small venous access (34%). A total of 18 patients died during this study period of which 6 were due to catheter-related complications.Conclusion: This study highlights complications associated with intermittent haemodialysis via CVC, mostly with bleeding and infections. The leading cause of mortality in this study is CLABSI. Practical concerns and fear contribute to delays in AVF creation. Early creation of arteriovenous fistula in pre-dialysis patients is vital in improving the outcomes of the patients.
Keywords
Full Text:
PDFReferences
Meng OL. Concise summary of essential statistics for year 2020, Malaysian Dialysis and Transplant Registry Report (MDTR). 2020.
Meng OL, Bavanandan S, Seong HL, Loo C. 29th Report of the Malaysian Dialysis and Transplant Registry. 2021.
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases 2020;75: S1–164.
Bream PR. Update on Insertion and Complications of Central Venous Catheters for Haemodialysis. Semin Intervent Radiol. 2016;33(1):31–38.
Alfarhan MA, Almatrafi S, Alqaseer S, Albkiry Y, AlSayyari A. Causes of the delay in creating permanent vascular access in haemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation 2020;31(10):1217-1224.
Wang L, Jia L, Jiang A. Pathology of catheter-related complications: what we need to know and what should be discovered. J Int Med Res. 2022;50(10).
Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, et al. Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrology Dialysis Transplantation 2008; 23:3219–26.
Parameswaran S, Geda SB, Rathi M, Kohli HS, Gupta KL, et al. Referral pattern of patients with end-stage kidney disease at a public sector hospital and its impact on outcome. Natl Med J India 2011; 24:208–13.
Wang K, Wang P, Liang X, Lu X, Liu Z. Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China. BMJ Open 2015;5:e007136.
Shah Z, Khan I, Dixe de Oliveira Santo I. Intraperitoneal Hematoma After Femoral Catheterization: A Case Report and Literature Review. Cureus 2022.
Maya ID, Allon M. Outcomes of tunneled femoral haemodialysis catheters: Comparison with internal jugular vein catheters. Kidney Int 2005; 68:2886–9.
Rathi M, Pinnamaneni VST, Sakhuja V. Non-imaging assisted insertion of un-cuffed, non-tunneled internal jugular venous catheters for haemodialysis: Safety and utility in modern day world. Biomed J 2016; 39:283–8.
Torreggiani M, Bernasconi L, Colucci M, Accarino S, Pasquinucci E, et al. Vascular Access, Complications and Survival in Incident Haemodialysis Patients. Kidney and Dialysis 2021; 1:88–99.
American Society of Anesthesiologists Task Force on Central Venous Access, Rupp SM, Apfelbaum JL, Blitt C, Caplan RA, Connis RT, et al. Practice guidelines for central venous access: a report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology 2012; 116:539–73.
Nayeemuddin M, Pherwani AD, Asquith JR. Imaging, and management of complications of central venous catheters. Clin Radiol 2013; 68:529–44.
Ge X, Cavallazzi R, Li C, Pan SM, Wang Y-W, Wang F-L. Central venous access sites for the prevention of venous thrombosis, stenosis, and infection. Cochrane Database of Systematic Reviews 2012;2018.
Osman OO, El-Magzoub A-RA, Elamin S. Prevalence and Risk Factors of Central Venous Stenosis among Prevalent Haemodialysis Patients, a Single Centre Experience. Arab J Nephrol Transplant 2014; 7:45–7.
MacRae JM, Ahmed A, Johnson N, Levin A, Kiaii M. Central Vein Stenosis: A Common Problem in Patients on Haemodialysis. ASAIO Journal 2005; 51:77–81.
Delistefani F, Wallbach M, Müller GA, Koziolek MJ, Grupp C. Risk factors for catheter-related infections in patients receiving permanent dialysis catheter. BMC Nephrol 2019; 20:199.
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases 2020;75: S1–164.
Seong HL, Mushahar L, Meng OL, Visvanathan R, Seng WH. Kidney replacement therapy. Clinical practice guidelines Ministry of Health Malaysia. Fourth, Post Graduate Kidney Society of Malaysia; 2017; p16.
Shechter SM, Skandari MR, Zalunardo N. Timing of Arteriovenous Fistula Creation in Patients With CKD: A Decision Analysis. American Journal of Kidney Diseases 2014; 63:95–103.
Chan KE, Hakim RM, Pulliam J. The '30-20-10' rule for renal care. Renal and Urology News. 2019.
Shechter SM, Skandari MR, Zalunardo N. Timing of Arteriovenous Fistula Creation in Patients With CKD: A Decision Analysis. American Journal of Kidney Diseases. 2014 Jan;63(1):95–103.
Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, et al. Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner-city nephrology clinic: a cohort study and survey of providers. BMC Nephrol 2017; 18:28.
Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection 2015; 43:29–36.
Atilla A, Doğanay Z, Kefeli Çelik H, Demirağ Md, Kiliç Ss. Central line-associated blood stream infections: characteristics and risk factors for mortality over a 5.5-year period. Turk J Med Sci 2017; 47:646–52.
Wright M-O, Decker SG, Allen-Bridson K, Hebden JN, Leaptrot D. Healthcare-associated infections studies project: An American Journal of Infection Control and National Healthcare Safety Network data quality collaboration: Location mapping. Am J Infect Control 2018; 46:577–8.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright © 2016 AMDI Publisher, Universiti Sains Malaysia.
Disclaimer : This website has been updated to the best of our knowledge to be accurate. However, Universiti Sains Malaysia shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.
Best viewed: Mozilla Firefox 4.0 & Google Chrome at 1024 × 768 resolution.